Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

Business Update, Final Results and Financing Agreement

30 Jun 2022

 Shield Provides a Business Update, its Final Results for the Year Ended 31 December 2021 and announces a financing agreement of US$10 million

Shield Therapeutics plc today reports a business update covering recent developments, its audited final results for the year ended 31 December 2021 and details of a financing transaction of US$10 million through a shareholder loan from AOP Orphan International AG (‘AOP’).  Upon completion this transaction will extend the Company’s cash runway to approximately the end of calendar 2022.

For full details click here.

Back to news